Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
brogger good article you found August 13, 2019... coming soon IT bra ...
(Well you must’ve admit the smart tampon makes the IT bra look completely more feasible, come on man,
really a Smart tampon !!!).
13
My telepathic skill sees news coming...
https://www.fda.gov/medical-devices/digital-health
Let’s see already have earlier FDA Class 2 clearance on the technology...
So let’s see if the FDA puts their money where their mouth is...(referenced link above).
Then maybe this eventually happens...
“The intended result of these activities is to accelerate CI's drive to possible significant value via generation of revenue by the end of 2019 or early 2020, through sales directly to physician clinics (based on information obtained from the Pilot Program), leading to a possible merger or acquisition potentially some time in 2020. It must be noted that the iTBra system has not yet been cleared by the FDA for marketing in the United States.
NOT YET 13...
My telepathic skill sees news coming...
https://www.fda.gov/medical-devices/digital-health
“Huge Business Potential”...Just love those words...tic toc
“Having the possibility to perform medical checks at one’s fingertips, while going about your daily business in fast-paced Hong Kong is truly game-changing and, at the same time, brings peace of mind to patients,” commented Grace Lau, Head, Management, Hong Kong, DKSH Hong Kong. “We see huge business potential for Cyrcadia Asia and we are dedicated to supporting Hong Kong companies to expand their innovative healthcare solutions in and beyond Hong Kong.”
http://dksh.com/global-en/home/media/news?id=tag:xml.newsbox.ch,2019-01-21:1101.1455.digest
“DKSH is driving education in medical channels through its strong sales workforce and will soon roll-out this medical device to the over-the counter markets in a one-stop-shop model for both Hong Kong and Macau.”
“Over The Counter”...Really Love Those Words...tic toc $$$
((Re-posted this article for those who have not read it))
Havn’t Given Up Mead...
4/10/19 “I understand. What I was told from an observer from a neighboring office is that the small but dedicated crew is essentially working non-stop week in and week out with next to no interaction, sometimes working from home. I am taking this observation as a positive sign. Limited staff working on a deadline. I am hoping for the best”
Meads last post before the heart attack, yes Mead very positive, better than an empty office...!
RIP Mead
CyrcadiaHealth.com
13...tic toc
So, product mfg., product delivered, product demand for clinical appl. good,
data base to grow, right on track for two part plan 1-Asia 2-USA
(Yes FDA full approval for commercial USA dist. as with any new med device
will be expected. Given the current sensitivity to breast cancer I foresee the FDA
working closely with us.
Feb interview again-
Yep lifeline biotechnologies investor update previously released...clinical release, ENHANCSD INVESTOR VALUE, etc.
https://www.apnews.com/b2a410b2d7def8abcc68c79a07f96332
(Previous article discusses patent, strategy, etc)
"The License and Collaboration Agreement between CI and CA brings advantages for both parties," said Royea. "The opportunity for early market entry and funding from the Asian operations brings additional funding into CI to exercise its option, under an Intellectual Property Asset Option Agreement with the technology's developer to acquire directly certain patents which previously had been licensed to CI. Those patents are in the process of transferring to CI to be fully owned by CI, and they are licensed to CA under the License and Collaboration Agreement. Furthermore, the License and Collaboration Agreement allows for CI and CA to cooperate on global expansion of the intellectual property portfolio."
Under the License and Collaboration Agreement, CI and CA have also established a joint venture, Cyrcadia Data Services, Ltd. to fund and develop the Cyrcadia health predictive analytics core lab. This entity will ensure improved accuracy in the technology as the companies feed in large volumes of data from their respective regions.
CI's CEO Matt Benardis, sees the new structure as a win-win for all parties. "The new partnership with Cyrcadia Asia, Ltd. provides an accelerated speed to market globally," said Benardis. "The Cyrcadia Health brand recognition that we can achieve together in large populations, along with the significant expansion of powerful intellectual property, is intended to maximize CI shareholder value as we move to our planned market launch here in North America. The joint venture of our unified predictive analytic core lab is intended to provide the highest possible accuracy for patients and providers of our technology throughout the world."
https://www.benzinga.com/pressreleases/17/04/p9339511/cyrcadia-inc-prepares-for-itbra-product-launch-and-expands-strategic-op
tic toc tic toc...
New, but old diff source...article:
https://www.google.com/amp/en.businesstimes.cn/amp/articles/106351/20190107/dense-breasted-women-at-risk-of-breast-cancer-high-tech-bra-aids-early-detection.htm
Good post Forever,
Canada has the same issue, women need to be informed
Key here is getting to the doctors...iTBra...Hopefully Cyrcadiahealth.com make that a major selling point.
“Huge Business Potential”...Just love those words...tic toc
“Having the possibility to perform medical checks at one’s fingertips, while going about your daily business in fast-paced Hong Kong is truly game-changing and, at the same time, brings peace of mind to patients,” commented Grace Lau, Head, Management, Hong Kong, DKSH Hong Kong. “We see huge business potential for Cyrcadia Asia and we are dedicated to supporting Hong Kong companies to expand their innovative healthcare solutions in and beyond Hong Kong.”
http://dksh.com/global-en/home/media/news?id=tag:xml.newsbox.ch,2019-01-21:1101.1455.digest
“DKSH is driving education in medical channels through its strong sales workforce and will soon roll-out this medical device to the over-the counter markets in a one-stop-shop model for both Hong Kong and Macau.”
“Over The Counter”...Really Love Those Words...tic toc $$$
((Re-posted this article for those who have not read it))
Build theeee church with me on hands...
Build theeeee bridge with me on hands...
But, f*ck meee one...goat...!
Just a little side entertainment !!!
Run baby ^20%...well least it’s something!
“One woman will die of breast cancer every 13 minutes in the US. Every 19 seconds, someone in the world is diagnosed with breast cancer. A man's lifetime risk of breast cancer is about 1 in 1,000. About 2,240 new cases of invasive breast cancer were expected to be diagnosed in men in 2013.”
https://www.dosomething.org/facts/11-facts-about-breast-cancer
https://www.dosomething.org/us/facts/11-facts-about-breast-cancer
Hope it goes to the brood market soooonnnn...
Time...next 6 months will be critical, positive results need to be reported !!!
(2hr wear time to 6 hrs ???)
Positive results will create news—which will drive interest resulting in incremental sales growth.
This is what Rob & Co. are betting on, thus the discussion about the rather large production capacity.
LLBO will be recognized if this occurs.
LLBO
Lifeline BioTechnologies, Inc.
Common Stock
0.0024
0.00028
13.21% ~~~~~~~~~~~~~~~~€|||||||||||||||||>
Just love that number ...13
“Over 45% ownership of Cyrcadia”—Get it together Jim Holmes !!!
“The Company recently transferred breast cancer detection technology to Cyrcadia, Inc. in exchange for 4,670,000 shares of Cyrcadia, Inc. common stock and a $110,000 cash and $220,000 promissory note. The additional 4,670,000 shares added to Lifeline's original 8,000,000 shares totals 12,670,000 shares. Lifeline's ownership is increased to over 45% of Cyrcadia, Inc., making Lifeline Cyrcadia, Inc.'s largest single shareholder.”
Source:
http://m.marketwired.com/press-release/lifeline-biotechnologies-updates-pinksheets-llbo-2224617.htm
The Mexicans can’t even build a flat road, let alone run a Government that’s not corrupt, and now they copy the iTBra attach some low level sensors to it & think they can diagnose early stage breast cancer...ha ha ha ahhh ha ha ha what a joke...
New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia Data Services Inc. (AI Cloud Data Base) which transmits analysis back to the Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch March 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following post after drinking a pot of coffee!
Just Enter any of the below listed post # in the search box above and click “GO”
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
#27131 PPS it’s long, but conclusion pps.22 or more (valuation only used sales factor of <1% of 700Million + women, also keep in mind “annual” breast screening >250Million clinical checks)
#27094 Co marketing intent, the short “it’s happening”!
#27061 Market size & Need, Summary-It’s Huge & Needed
#26944 Insurance Ins perspective-Ho Ho Ho Merry Christmas, AARP nailed it!
#27037 Number of breast cancer cases & importance of earl detection- Your life may depend on it
#26370 iFlytech Corp.-Invest in healthcare through acquisition- Say what ?
#25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia waiting!
Quote:
“On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer every 13 minutes.”
Source Article:
https://www.nationalbreastcancer.org/breast-cancer-facts
https://www.reuters.com/brandfeatures/venture-capital/article?id=14381&pid=3036&pp=undefined
Hell just buy some shares sit back & think of Green Grass & High Tides...tic toc
(But seriously how do I really feel about a speculative penny stock I’ve owned for 10 yrs., & many release target
dates missed...? Well face to face while enjoying our favorite beverage, I’d say son of a bitch this thing is really
finally going to happen...and if it saves just one life of the women who would of died every “13” minutes I’ll crack a big smile & say job well done Cyrcadia team !)
Advertise Her
Rob hired in 2013 as CEO to take it to market.
Became CEO Asia last few years...
~47% LLBO Cyrcadia Health ownership...
Breast cancer screening: a growing world market12.07.2017
A short view on different markets
~250,000,0000 MILLION Breast Screenings Worldwide ...Say What???
“Breast cancer is the most common cancer in women worldwide, and the number of women affected continues to increase.1 There is thus a large need for early detection options.
China is therefore one of the largest markets for breast cancer screenings, along with the United States, Brazil, Japan, and Germany.” Etc etc.
https://www.healthcare.siemens.nl/mammography/news/breast-cancer-screening-growing-worldwide.html
And to think I only used a fraction of that market for valuation & there’s only one way in to the show...tic tic tic toc...
Welcome PPS ~.22—New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast & looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia AI cloud data center which transmits analysis back to her & Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following POST after drinking a pot of coffee!)))
Previous Informative Post:
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
27131 PPS it’s long,but conclusion: pps.22 or more
27094 Co marketing intent: the short “it’s happening”!
27061 Market size & Need: Summary-It’s Huge & Needed
26944 Insurance Co perspective: Ho Ho Ho Merry Christmas, AARP nailed it! $$$
27037 Number of breast cancer cases & importance of earl detection: Your life may depend on it
26370 iFlytech Corp.-Invest in healthcare through acquisition: Say what ?
25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia/World
waiting. Other info.
Hell just buy some shares sit back & think of green grass & high tides!!!
Jim Holmes, Lifeline’sCyrcadia Health CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product. Our tested and proven technology, from our multiple rounds of clinical trials, has shown early identification of breast tissue abnormalities, many of which could lead to cancers, potentially can save lives and costs. We/Cyrcadia prepared an analysis of cost savings for a presentation to a World-Wide Major Insurance Company. The medical cost comparison was identifying breast tissue abnormalities and breast cancers at stage 1-3, vs the abnormality progressing to stage 4 or 5 cancer. The cost savings was estimated at over $300,000 per patient. Applying this projected and estimated cost savings to this large insurance, was in the hundreds of millions of dollars annually. (PPS anybody’s guess ?).
I just love reading this, so I posted again!!!....”Increasing number of users”.
Cyrcadia Gets Iflytek Backing to Take Breast Cancer Detection Patches to Market
LIAO SHUMIN
DATE : JUL 18 2018/SOURCE : YICAI
Cyrcadia Gets Iflytek Backing to Take Breast Cancer Detection Patches to Market
(Yicai Global) July 17 -- Cyrcadia Asia, a startup developing smart breast cancer detection devices, has bagged CNY25 million (USD3.8 million) in pre-A funding led by Chinese tech giant Iflytek.
The money will help the company launch in Hong Kong and other Asian markets this year, and provide a foundation for its A-round this quarter, online news site The Paper reported. The firm penned license deals with United States-based Cyrcadia Health to produce and distribute the devices -- patches worn by women for two hours a month that let them monitor the health of their breasts via a mobile application.
Iflytek is the biggest artificial intelligence firm listed in China, and began its foray into healthcare in 2016. Dr. Tao Xiaodong, an expert with medical imaging and computer-aided diagnosis experience at Philips Healthcare and GE Healthcare, founded the department and is set to become a director at Cyrcadia Asia.
The patches detect cancer by observing metabolic changes, Tao said. This makes up for shortcoming in current imaging technologies and human interpretation, and provides a convenient way for women to monitor their health. The increasing number of users could make the service the largest breast health incidence database, and provide information for research into cancer preventions and treatments, he added.
Iflytek took quickly to the healthcare sector, and in November 2017 its AI robot Xiaoyi passed the national medical exam, the test required to qualify as a doctor in China. The bot scored 456 points, 96 more than the pass mark. The company now runs AI services at more than 50 hospitals in its home province an Anhui, helping doctors to diagnose and treat diseases and interpret medical images.
Advertise Here
iHub NewsWire
OK ...Cyrcadia Data Services satellite towers should be smokin before to long...
trade them shares
, but don’t get caught empty handed...tic toc
Cisco very happy with 82% effective diognoses rate for iT Bra vs
42% using traditional breast cancer tech on dense breast tissue.
Look for some noise from Cisco later this year, when the product
distribution begins in Asha, land of the dense breast tissue market.
(Preliminary breast tumor “blood”test Only 33% effective, and a very
long way until market rollout 5-6-7 yrs???)
https://www.itspmagazine.com/from-the-newsroom/detected-a-movie-iot-wearable-tech-breast-cancer-and-cisco
Jan 22, 2018
“IT appears the gamble has paid off for Cisco & Rob Royea.”
PPS Target .03-.05 fall/winter 2018
Cisco iT Bra article for newbies:
Innovation
With Early Cancer Detection, IoT Saves More than Money—It Can Save Lives
4100pts
Maciej Kranz - May 24, 2017 - 0 Comments
This week at the Internet of Things World Forum, we’ve been hearing a lot about the transformational value of the Internet of Things (IoT) across many industries – manufacturing, transportation, agriculture, smart cities, retail, and finance. So many new solutions are on display that help organizations either save or make money. But in healthcare, IoT can actually do more than that, it has the potential to save lives.
You may be thinking, “Of course—wearables, remote monitoring, performance tracking. These concepts have been around for a while now.” And yes, these technologies and devices are already working to improve health and fitness. One recent development, however, has really captured my attention because of its potential to help with early detection of breast cancer. That’s the idea behind the connected bra—dubbed the” iTBra” by its inventor, Rob Royea, CEO of Cyrcadia Health. With embedded temperature sensors, this new kind of wearable technology tracks changes in temperature in breast tissue over time. It uses machine learning and predictive analytics to identify and classify abnormal patterns that could indicate early stage breast cancer. And women will be glad to know that they just need to wear the iTBra for 2 to 12 hours once a month as they go about their daily activities—there’s no painful squashing or prodding or radiation involved.
The iTBra fits comfortably under virtually any normal bra and can transmit results to a smartphone.
This technology marks a vast improvement over traditional mammography, which generally doesn’t detect the presence of cancer until it is in Stage 3 or 4. It is also much more accurate than mammography, which produces a high number of both false-positive and false-negative results. Currently, more than 70 percent of biopsies that are done as a result of a suspicious mammogram turn out to be non-cancerous tissue. And in women with dense breast tissue, mammograms miss the presence of cancer more than 50 percent of the time. Because the iTBra relies on different detection technology, its false negative rate has so far been 17.3 percent for all tissue types—an improvement for all women, but especially for those with dense tissue.
Connected bra technology is many times more accurate than mammography in detecting the presence of cancer.
“Detected” is a new short documentary film sponsored by Cisco that shows the development of the iTBra, from the seed of an idea to its acceptance for clinical trials. The power of this documentary is not only about the ground-breaking idea itself, but also about the innovation process. I have been a keen observer and practitioner of innovation and co-innovation for years, and therefore I appreciate how the film realistically depicts the entrepreneurial struggle—a great idea, some false starts, some wrong turns. We also see Rob Royea’s grit and determination as he doggedly persists through obstacles, builds a coalition of the willing across the globe, and spreads his enthusiasm and passion about the project to people around him.
Rob Royea, right, discusses circuitry design with a development partner in Israel.
The connected bra idea is already so powerful by itself; but this is just a start. As Rob Royea says in the film, “What if you can screen three million people in Asia in a single year? What if you can create this mega database through the Internet, that can analyze how some people, versus others, have cancer?“
This is where IoT, in combination with the cloud, machine learning, and analytics capabilities, can truly become transformative. Mammograms—and the radiology expertise needed to interpret their results—are still out of reach for billions of women, especially in poor countries. Now, with inexpensive, non-invasive technology, you can now screen millions of women who have never had access to screening before. And in the process you can gather massive amounts of anonymized data that can help us research and hopefully better understand what factors contribute to a woman getting breast cancer in the first place. In a world where more than half-a-million women die from breast cancer each year, such connected IoT solutions can not only help cancer detection, but also cancer prevention.
The connected bra is just one of the reasons IoT in healthcare is especially exciting to me. Combined with rapid advances in areas ranging from bio- and DNA engineering, to robotics, prosthetics, and remote care, IoT is poised to dramatically improve many aspects of our lives—enhancing not only how long, but also how well we live. This is why I believe it is so important to rally behind entrepreneurs such as Rob Royea. We should support the efforts of current innovators and create incentives and programs for new ventures in the IoT healthcare field. Because in healthcare, the stakes are not just about efficiency or productivity; they’re about our lives.
Tags:
connected braCyrcadia HealthDetectedhealthcareinternet of thingsIoTiTBraMaciej KranzRob Royea
In an effort to keep conversations fresh, Cisco Blogs closes comments after 60 days. Please visit the Cisco Blogs hub page for the latest content.
Advertise Here
iHub N
“Just another tool”... Ohio State Uni Cancer Cntr. tic toc...iT Bra could be link to early breast cancer detection
10tv.com
PUBLISHED: 05/12/16 10:06 AM EDTUPDATED: 05/19/16 06:21 PM EDT
Columbus, Ohio
Ohio State University is testing what could someday become "magic 8-ball" for diagnosing breast cancer.
It's called the iTBra.
Doctors at the OSU James Cancer Hospital and Solove Research institute call it hope.
"The concept behind it is basically that when cancer forms in the breast, it changes the circadian rhythm in the breast," explains Dr. William Farrar, the principal Investigator behind a new clinical study now underway at OSU.
When a tumor builds its own blood supply, it increases heat. Circadian rhythm is the differentiation in temperature over a period of time.
The "bra" is more in actuality, a medical device that sticks to the breast with metal sensors embedded that can detect the rise in temperature. Dr. Farrar says this technology is particularly important to women who have dense breast tissue.
"The whole idea about when to do mammograms, how often you get them; this may help identify what group of patients need to get a mammogram earlier and in the dense population, which ones need to get an MRI or some other testing to detect cancers," he adds.
Cyrcadia Health, based in Reno, Nevada, is the company developing this wearable technology now in clinical trial at Ohio State. According to its website, the iTBra demonstrated an 87% correlation to a verified, clinical diagnosis of breast cancer including with those patients with dense breast tissue.
Dr. Farrar, who started the initial study of the iTBra in 1988, says this new phase of testing will focus on women who have had mammograms and have been told by their doctors to return for a biopsy.
"It's the same principle," says Dr. Farrar.
"Increased heat production, we can find it easier. The computer and technology behind it has improved tremendously."
Dr. Farrar stresses that by no means does this new technology mean women should replace getting mammograms. He says he considers this as just another tool in the toolbox for doctors in the fight against cancer. However, Dr. Farrar says the exciting aspect of this study is that someday, women might one day be able to buy this "smart" bra at any drug store and get results similar to a pregnancy test.
If you would like more information about this study, call the James at 1-800-293-5066.
Register or donate: Susan G. Komen Race for the Cure in Columbus
Advertise Here
Nat Cancer Institute: “WOW”. exceeds 25,000,000 Million tic toc tic toc...
Prevalence of Mammographically Dense Breasts in the United States:
Conclusion
The prevalence of dense breasts among US women of common breast cancer screening ages exceeds 25 million. Policymakers and healthcare providers should consider this large prevalence when debating breast density notification legislation and designing strategies to ensure that women who are notified have opportunities to evaluate breast cancer risk and discuss and pursue supplemental screening options if deemed appropriate.
Topic: body mass index proPrevalence of Mammographically Dense Breasts in the United States cedure censuses health personnel mammography breast statutes and laws breast cancer surveillance, medical breast neoplasm screening national health and nutrition examination survey breast density
Issue Section: Article
Mammographic breast density is a strong risk factor for developing breast cancer (1,2) and also impairs mammography performance (3–6). At least 12 states have recently passed legislation that mandates the disclosure of mammographic breast density information directly to women with dense breasts, along with language communicating that breast density may obscure abnormalities on a mammogram and that these women may benefit from supplemental screening tests (7). Similar legislation is under consideration by many other states and at the national level (8). The number of women potentially affected by this legislation has not been well characterized.
Is Telemedicine the Future of Care
Cyrcadia Health
(Lifeline Biotechnologies
LLBO: 07-.12 target PPS)
Huge mkt for women who want home privacy & life saving ability to do a simple reliable breast examination between annual breast check ups, the iT Bra allows this peace of mind. (And with the new breast screening guidelines out recommending screening every other year after age 54, the IT Bra will be ideal for those long in between screenings, oh and the new guidelines also don’t recommend the old self examination “by hand”, hell let’s just let the tumor grow into an elephant. What’s left the iT Bra or a crystal ball, which would u choose ???)
(Gene identification for breast tumor risk testing is NOT going to change that in any way.)
One such very large medical Co. that is currently being approached by Cyrcadia Health (iT Bra) is-Kaiser Permanente Co. ( mentioned in AARP article below),
Kaiser preaches “Early Diognostic Prevention”...& the iT Bra is something they cannot afford to shrug off.
Virtual Medical Care Huge Future:
Glad to see that Cyrcadia Health will be indirectly involved with Kaiser Permanent
(I brought this up as a target mkt below, prior to their 2017-2018 report release, glad to see they are going right
after the Virtual med mkt.)
Let’s just look at what is literally appearing before our eyes to help answer this question
“This is the future of Medicine...”
Telemedicine Revolution (patients/doctors converse anywhere)—Fact, Hospital Without Patients (virtual care) 2016 mega growth industry had sales of $14 Billion Dollars, growth projection
expected to $36 Billion Dollars by 2020, (2yrs)WOW, project that growth line and
You fall out of your seat (iT Bra I would say is properly named).
Mercy Virtual medical bldg is 6 miles from my home, a mega structure loaded with over
400 doctors, nurse specialist,and med technicians (not one hospital bed). All who supported more than 44 hospitals in the Mercy network,
in over 10 Midwest states (had over 750,000 thousand patients just last year.)
(Why? Patient convenience, privacy, more efficient healthcare, saving money & more important life’s).
1)Mercy Virtual 2)Kaiser Permanente 3)Cleveland Clinic 4)Intermountain Health Care, 5)Dignity Health,
6) Avera Health—just names of mega hospital Major healthcare providers networks with millions of patients getting in on the game...
AND One hell of a big game it’s going to be.
One strategy these players are aiming for is Primary Preventaive Medicine “Primary Care”, ahhh musical notes
to who else, but our cheer leaders the Insurance Companies, a growing garden of health care medical care
payout savings, and wow are they cheering...!
Go iT Bra
So who do you think Cyrcadia Health is targeting ask your self ?—why the extensive clinical trials when they already have FDA Clearance, and mktg/sales program in Asia just about to begin 2018, because they want to get it right (their AI Artificial intelligence algorithm, also just recently brought to my attention the medical community is wanting to see the clinical trial data ASAP when it can be released-this will be huge for Cyrcadia Health)
This iT Bra no pun intended fits right into the “Telemedicine Revolution” and the timing could not be better.
(reducing anxiety, commute time/expense/carbon foot print, giving privacy and saving a life for millions of women connected all over the world, ask yourself would you pay less than $100 to possibly save your life & not be exposed to low level radiation, what would an insurance co pay to save millions of dollars ?
Yes the TeleMedicine evolution is here fellow investors (I am currently holding 2 Mil shares LLBO
in case anybody was wondering, I have no connection with the company and do my own research)
My hats off to Cyrcadia and Mercy Virtual for preventing/ reducing early unnecessary deaths,
hospital admissions, emergency dept visits, saving untold millions of dollars.
The price of admission is life...
I guess only time and a life saved will answer the question what if
DETECTED ?
Previous post # 24768, which u can enter the post num at the top GoTo search box, has information
on some current investors as well as clinical trial data.
Good day to all.
Source:
AARP magazine article Feb/March 2018 “Is telemedicine the future of care” & “The Digital Doctor Is In” , explores how telemedicine is transforming healthcare.
Excellent article and anyone that invest in any kind of healthcare should definitely read.
(I know one thing the executives at Cyrcadia Health are).
More Info:
Mercy Virtual & the other Mega health institutions, again discussed in this months AARP
journal (April/May) as well as Cisco (per my prior investigative post below), continue to educate the
public on this explosive growth industry-“Virtual Health Care”.
Cyrcadia Health-get the data and the iT Bra out !!!
This technology has never “NEVER” been tested & had advanced algorithmic data collection
based on the very latest technology that it has today...the sensitivity of the senors & AI source
interpretation of data, surpassed Oxford when they were also running test many years ago.
Sensitivity (detection) for women with other conditions is approximately 60%(ie: dense breast tissue & that is many women), but the
iT Bra has a very large
improvement in final outcome sensitivity (Detected).
American Cancer Society facts
“Radiation exposure”:
Because mammograms are x-ray tests, they expose the breasts to radiation. The amount of radiation from each mammogram is low, but it can still add up over time.
(Time ???)
A false-negative mammogram looks normal even though breast cancer is present. Overall, screening mammograms do not find about 1 in 5 breast cancers.
(=20%, & I have to wait one more year for another mammogram, not if I have the iT Bra!)
Worldwide over 1.7 Million
women will be diagnosed with breast cancer.(25% of all new cancers in women are breast cancer, it is the fifth most common cause of death from cancer in women.)
Netherlands study:
a recent large-scale service screening report from the Netherlands involving almost 175,000 cancers with linked data mammography, pathologic conditions, and breast cancer death outcomes. Breast cancer mortality increased significantly in both studied cohorts (before and after institution of modern chemotherapy) with increasing tumor size for tumors as small as 10 mm. The major conclusion of the report was that “Diagnosis of breast cancer at an early stage remains vital,”
VITAL—hence, metrics involving tumor size, lymph node status, and cancer stage continue to be important indicators of quality performance.
****************
(so we have 20% of cases not detected & tumor SIZE so important & I’m going to wait over two years for “2” mammograms???
iT Bra at least gives me a fighting chance.
I truly believe it would be totally insane for the virtual medical market not to be taking a very close look at this technology “iT Bra” and doing what they can to support it.
iFlytec(Keda Xunfei) & Cyrcadia Health
Bloomberg Nov, 2017 iFlytec video (6 months after iT Bra investment)
“China’s iFlytec focuses on smart healthcare” quoted...
—“Smart Healthcare growth (acquisition) is the primary Company smart tech strategic focus”
—Assisted diognostic system accuracy for improved cancer diognosis through AI imaging”
—“Out International strategy of investing in USA Co’s WILL assist this goal”
—Activities are being conducted at our new Silicon Valley office”
(iFlytec is the primary $3.8 Million only Investor)
Read between the lines, LLBO S/B trading above .05 cents per share.
Luke Minford, CEO of Rouse, said:
“We are delighted to see Cyrcadia Asia close its seed funding, especially with a lead investor as exciting as iFlytek, and we look forward to supporting the next stage of the company’s growth. Rouse has always been an entrepreneurial firm that is dedicated to helping companies obtain real value from their intellectual property assets. Our Ventures program proves that we can go beyond traditional consulting services and be instrumental in bringing a ground-breaking and potentially life-saving technology to the world. We are fortunate to have found in SCP a partner with outstanding contacts and experience in capital raising who can work so seamlessly with us.”
Tic tic tic tic and...TOC, no doubt it’s going to happen:)
The Mary Kay Foundation
Cancer News And How It Affects You
05-17-2017 9:09 AM
Welcome to The Wednesday Report. This week, we’re giving you the top headlines in cancer news and how it might affect you:
The breast cancer doctors missed. Inflammatory breast cancer made international headlines this month when a Texas mom of two told her story. When Jennifer Cordts noticed a rash on her breast — much like a sunburn — she got medical help. Unfortunately, the mammogram showed no lump and no tumor. And her lab work returned normal. So, no diagnosis. When the redness didn’t go away, she turned to the Internet. After pressing her doctors for more answers, she was finally diagnosed with stage four, inflammatory breast cancer. That diagnosis came nearly one year after her initial symptoms. You can see her entire story here.
What you can learn. Unfortunately, inflammatory breast cancer symptoms mimic other diseases and conditions. That’s why doctors miss it. We want to spread the word about the symptoms. Women, trust your instincts. Don’t be afraid to get a second opinion. And know the signs. For more information, to cancer.gov.
Can a bra help with early detection? Maybe. I read about two types this week.
Bra inserts. The iTBra inserts, by Cyrcadia Health, may be ready for market launch in Asia in late 2017 or early 2018. The iTBra consists of two wearable breast patches, which can fit inside any bra, that detect temperature changes within breast tissue. Heat changes within breasts can be a very early sign of cancer. This new technology offers advantages especially to women with dense breasts. Mammograms can often miss small tumor growth in dense breasts.
The U.S. FDA has already approved the itBra sensors. Clinical trials in the U.S. show an 80 percent accuracy rate of detecting tumors, which compares with mammography. So why the launch in Asia first? Seventy percent of Asian women have dense breast tissue, which leads to a higher tendency to develop breast cancer. That compares to only 40 percent in the western population. However, Cyrcadia expects to launch in North America shortly after the Asian launch. You can read the entire press release here.
Let us know what you think about our first issue of The Wednesday Report. We always love to hear from you.
Stacy Graves is a contributing editor of The Mary Kay Foundation? blog and website. She and her husband, Glen, are raising two teen boys. When she’s not writing, she’s probably at a fitness class, volunteering at church or the boys’ school, or drinking a healthy smoothie at the local juice bar. She’s worked in some type of communication role for Mary Kay Inc. or The Mary Kay Foundation since 1994 — loving every minute. She’s passionate about everything Mary Kay. You can connect with her by her website or LinkedIn.
tagged: cancer, breast cancer, 2017, The Wednesday Report
(And like the broken record I am fellow longs, again my god this is beginning to remind me of my long hold of Cytosorbent shares, it’s coming, no crystal ball how high, but IT IS COMING !)
“Large volumes of data...”.
Cyrcadia Data Services (Cds) Limited:
Summary
Cyrcadia Data Services (Cds) Limited was set up on Thursday the 20th of April 2017. Their current partial address is County Wicklow, and the company status is Normal. The company's current directors have been the director of 32 other Irish companies between them; 4 of which are now closed.
Company Vitals
* Company Name:?Cyrcadia Data Services (Cds) Limited
* Time in Business:?1 Year
* Company Number:?602697
* Current Status:?NORMAL?
* Principal Activity:?[6311] Data Processing, Hosting and Related Activities
* May Trade As:?Cyrcadia Data Services Cds Ltd
* ADD MY COMPANY DETAILS
*
* Registered Address:?No. 1 Main Street,?Blessington,?County Wicklow
* CDS Cyrcadia Data Services Limited Co# 602697 Registered 4/20/2017 (CRO Gazette 2017 pg4/7)
{Cyrcadia, Inc. Prepares for iTBra™ Product Launch and Expands Strategic Operations to Asia
Apr 25, 2017 Cyrcadia Data Services, Ltd.is a joint venture between Cyrcadia, Inc. and Cyrcadia Asia, Ltd., as an Ireland-based corporation...
Anonymised data is communicated directly to the Cyrcadia's core lab for analysis via your mobile device...Under the License and Collaboration Agreement, CI and CA have also established a joint venture, Cyrcadia Data Services, Ltd. to fund and develop the Cyrcadia health predictive analytics core lab. This entity will ensure improved accuracy in the technology as the companies feed in “large volumes” of data from their respective regions.}
April 20 New Co Registration:
https://www.cro.ie/DesktopModules/EasyDNNNews/DocumentDownload.ashx?portalid=0&moduleid=1179&articleid=1089&documentid=11370
https://www.benzinga.com/pressreleases/17/04/p9339511/cyrcadia-inc-prepares-for-itbra-product-launch-and-expands-strategic-op
O/S is not speculation it’s hard data. Speculative subjective growth stock valuation is subjective, I’ve done my analysis & sit quite comfortably on my 1.9 million shares (.05-.07 soon, .22 longer term on current data).This
stock was a day trader 10 yrs ago for me, finally a long term position for speculative growth stock portfolio.
While market cap represents the market perception of a company’s valuation, it still remains the overall market perception and may not necessarily represent the true picture.
Speculative growth investing is highly attractive to many investors because buying stock in emerging companies can provide impressive returns...
Growth investors investigate whether the company has the potential for excelerated revenue streams going forward, I’d say we have an open field of growth coming as we have no competition.
Post #27131–PPS valuation (don’t like it, that’s fare, but if your going to claim too many O/S, back it up)
Tic toc tic...
New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia Data Services Inc. (AI Cloud Data Base) which transmits analysis back to the Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch March 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following post after drinking a pot of coffee!
Just Enter any of the below listed post # in the search box above and click “GO”
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
#27131 PPS it’s long, but conclusion pps.22 or more (valuation only used sales factor of <1% of 700Million + women, also keep in mind “annual” breast screening >250Million clinical checks)
#27094 Co marketing intent, the short “it’s happening”!
#27061 Market size & Need, Summary-It’s Huge & Needed
#26944 Insurance Ins perspective-Ho Ho Ho Merry Christmas, AARP nailed it!
#27037 Number of breast cancer cases & importance of earl detection- Your life may depend on it
#26370 iFlytech Corp.-Invest in healthcare through acquisition- Say what ?
#25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia waiting!
Quote:
“On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer every 13 minutes.”
Source Article:
https://www.nationalbreastcancer.org/breast-cancer-facts
https://www.reuters.com/brandfeatures/venture-capital/article?id=14381&pid=3036&pp=undefined
Hell just buy some shares sit back & think of Green Grass & High Tides...tic toc
(But seriously how do I really feel about a speculative penny stock I’ve owned for 10 yrs., & many release target
dates missed...? Well face to face while enjoying our favorite beverage, I’d say son of a bitch this thing is really
finally going to happen...and if it saves just one life of the women who would of died every “13” minutes I’ll crack a big smile & say job well done Cyrcadia team !)
Advertise Her
Insurancenewsnet.com - 2015-03-13 12:57
“I think this holds tremendous potential for our industry,” he predicted. It could “change the foundational structure of how we build products, how we price products, and even how we go to market,” and also how consumers expect to interact with the industry and with their doctors.
“Truly, I believe it will be revolutionary for the industry.”
He pointed to a wearable breast cancer detection device, called an “iTBra,” from Cyrcadia Health. It can be worn inside any normal bra for a few hours. The sensors pick up heat patterns and transmit data to the physician via a smart phone.
tic toc tic toc...
“Sell it & they will come” ...
Aug 13, 2018 ...
Valuation LLBO ...”Quote:
“On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer every 13 minutes”. (very sad, my mom was one of them)
New investors: A women with the odds of 1:8 getting breast cancer over the course of her life has her hand on her breast looks into a mirror, seeing her reflection there is no hand, but instead she is wearing the iTBra tested
& proven technology with FDA approval & she ask herself my hand for early tumor detection or proven advanced technology for $150 total annual cost which includes 12 screening uploads to Cyrcadia Data Services Inc. (AI Cloud Data Base) which transmits analysis back to the Physician (Ins Cos also if requested), in just minutes ?
So I ask you, how many lottery tickets would u buy with 1:8 odds that’s right MANY, well with over 700 Million
women between 20-60 age don’t u think we may sell some iTBras...!
Expected Asia launch Jan 2019, then world roll out. Backed by worlds largest artificial intelligence
Co-iFlytech Corp., Cisco Corp., & currently in talks with major Health Ins Co’s.
(((If u really need to know more scan this forum many good people have posted “Factual” info.,
and/or read the following post after drinking a pot of coffee!
Just Enter any of the below listed post # in the search box above and click “GO”
#27171 PHd cancer researcher perspective Hint: U may be induced to buy more shares!
#27131 PPS it’s long, but conclusion pps.22 or more (valuation only used sales factor of <1% of 700Million + women, also keep in mind “annual” breast screening >250Million clinical checks)
#27094 Co marketing intent, the short “it’s happening”!
#27061 Market size & Need, Summary-It’s Huge & Needed
#26944 Insurance Ins perspective-Ho Ho Ho Merry Christmas, AARP nailed it!
#27037 Number of breast cancer cases & importance of earl detection- Your life may depend on it
#26370 iFlytech Corp.-Invest in healthcare through acquisition- Say what ?
#25922 (now drink more coffee, lots of it), The technology, Virtual medicine growth, Mkt size, Asia waiting!
Quote:
“On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer every 13 minutes.”
Source Article:
https://www.nationalbreastcancer.org/breast-cancer-facts
https://www.reuters.com/brandfeatures/venture-capital/article?id=14381&pid=3036&pp=undefined
Hell just buy some shares sit back & think of Green Grass & High Tides...tic toc
(But seriously how do I really feel about a speculative penny stock I’ve owned for 10 yrs., & many release target
dates missed...? Well face to face while enjoying our favorite beverage, I’d say son of a bitch this thing is really
finally going to happen...and if it saves just one life of the women who would of died every “13” minutes I’ll crack a big smile & say job well done Cyrcadia team !)
Most certainly hope u get better Mead.
13-3 Super Bowl was something, I’m out of town traveling my wife & some friends called asking me if I fixed the game !!! (they are all aware of 13 in my life, which I basically don’t even discuss or post anymore because it’s a daily occurrence now) ! Who knows maybe some strange buying frenzy will take LLBO to $13 pps “say what”.
tic toc
13